Reuters logo
4 个月前
BRIEF-Bristol-Myers enters collaboration to identify predictive biomarkers across multiple tumor types, immunotherapy agents
2017年3月30日 / 上午11点22分 / 4 个月前

BRIEF-Bristol-Myers enters collaboration to identify predictive biomarkers across multiple tumor types, immunotherapy agents

1 分钟阅读

March 30 (Reuters) - Bristol-Myers Squibb Co:

* Bristol-Myers Squibb enters collaboration to leverage Foundation Medicine's molecular information platform to identify predictive biomarkers across multiple tumor types and immunotherapy agents Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below